Harvard consortium blueprints $50M cell and gene therapy center — but can they actually foster lower drug prices?
Harvard is spearheading a consortium that has set out to build a $50 million center aimed at quickening the development of new and far more …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
